Class II · Moderate risk Terminated
Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe
Reason Lack of assurance of sterility.
Bevacizumab
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Lack of assurance of sterility.
What was recalled
Bevacizumab, 1.25 mg/0.05 mL, 31G MJ Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901
- Recalling firm
- Pacifico National, Inc. dba AmEx Pharmacy
- Origin
- FL, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-1850-2019
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Bevacizumab recalls
See all
Class II · Moderate risk Ongoing
bevacizumab
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated
Bevacizumab
Reason Lack of Sterility Assurance
Class II · Moderate risk Terminated
Bevacizumab 1.25 MG/0.05 ML Solution for Injection
Reason Lack of Assurance of Sterility
Class III · Low risk Terminated
Bevacizumab 2.5 mg/0.1 mL
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.